Recently, the advances in perfluorocarbon nanoparticles have been introduced to expand the diagnostic and therapeutic capability of ultrasound molecular imaging, a non-invasive diagnostic imaging, which passed from robust anatomical presentation to detection of physiological processes and recognition of specific tissue epitopes at the cellular level. The good properties of perfluorocarbon nanoparticles, such as nontoxicity, small size, phase-shift capability, etc., have been resulted in tremendous potential prospects in clinical application. Herein, this review focuses on the mechanisms of perfluorocarbon nanoparticles in terms of phase transition and ultrasonic theranostic. And the potential applications of perfluorocarbon nanoparticles in ultrasound medicine are also discussed.
Introduction
Ultrasound as a common modality for diagnosis and therapy in clinical medicine due to its intrinsic tissue penetration and high safety [1] [2] [3] demonstrates cost-effective, portable, non-ionizing, non-invasive and real-time characteristics compared with other imaging modalities such as X-ray imaging, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) [4, 5] . However, the poor quality on imaging and diagnosing of ultrasonography seriously retards further development of its abilities on the detection of diseases in the early stages, particularly for diagnosing tumors. Fortunately, the microbubbles as a contrast agent (CA) have dramatically enhanced diagnostic capabilities of ultrasonography due to their high acoustic impedance for considerable improvement in echogenic properties [6] [7] [8] [9] . But the relatively large size of microbubbles (typically two to ten micrometers) does not permit successful extravasation into tumor tissues as a result of the fact that the largest pores existing in the microcirculations of tumors are no more than 700 nanometers [10] . Additionally, the relatively large size induces microbubbles to be rapidly captured by the reticuloendothelial systems (RES), leading to the very short blood circulation time (minutes) and low amassing quantities in the tumors [11, 12] . Comparatively, the specially nano-sized bubbles which have overcame this disadvantage in terms of the relatively large size, nevertheless, have just limitedly contributed to enhance the ultrasound imaging because that the nonlinear backscattering is significantly dropped with their diameters decreased [13, 14] , and extraordinary image processing algorithms will be needed to increase the signal-to-noise ratio for detection of tumors tissues [15] .
During the last decade, advances in nanomedicine have permitted nanoparticles encapsulated various imaging agents, targeting moieties and therapeutic drugs to be a container of various functionalities [5, [16] [17] [18] [19] [20] [21] [22] [23] . One of the most promising examples is the perfluorocarbon (PFC) nanoparticles, because its characters of nontoxic biocompatibility and low solubility in aqueous liquids are extremely essential for medical application [24] [25] [26] [27] . The most important thing is that PFC nanoparticles advance a way to solve the above problem for the reason that they would effectively accumulate in tumor tissues beyond to blood vessels and then convert into microbubbles under ultrasound irradiation to enhance the ultrasound imaging [19, 28, 29] . In that case, the ability of PFC nanoparticles to combine imaging efficacy and therapeutic capability may remarkably improve the early assessment of response to treatment and considerably promote the development of personalized therapy [21, 30, 31] . Therefore, in what follows we will focus on PFC nanoparticles in response to the ultrasound-induced phase transition.
The Machanism of Vaporization in PFC Nanoparticles
Recently, Acoustic droplet vaporization (ADV) has been a considerably exploited phenomenon that liquid droplets are induced to convert into vapors under the action of ultrasound irradiation. It has been known for more than 15 years beginning with a literature by Apfel, who described that a technically designed PFC nanoparticles can transform into microbubbles in the condition of the application of acoustic waves [32] . The name "acoustic droplet vaporization" was given in 2000 by Kripfgans [8] . From then award, ADV has been profoundly investigated in the group works of Michigan University with albumin coated perfluoropentane (PFP) nanoparticles, which illustrated substantially applications PFC nanoparticles with ADV in terms of drug delivery, thrombolysis, and gas embolism, etc. [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Table 1 lists some parameters of candidate perfluorocarbons.
Thermodynamics of Vaporization
The first related concept is the thermodynamic phase state, such as solid, liquid, and gas. Both solid and liquid have a vapor pressure, which increases with the growth of the temperature of the condensed phases. The condensed phase maintains its intrinsic state, liquid or solid, when the vapor pressure is no more than its surrounding pressure. While, once the increase of vapor pressure and/or the decrease of surrounding pressure result in that vapor pressure surpass its surrounding pressure, the molecules will promptly escape from a liquid or solid phase to a gas phase. The "normal boiling point" (as shown in Table 1 ) is the temperature where the vapor pressure of a PFC liquid is around 101kPa. And during this circumstance, the equilibrium between gas and liquid phases is obtained.
Acoustic droplet vaporization introduces these properties of the thermodynamic phase state to achieve the emergence of phase transformation, not necessarily any changes in temperature, due to the fact that acoustic waves can be used to manipulate the vapor pressure of the liquid. For small droplets trapped by elastic lipid shells, however, even though the vapor pressure of liquid droplets is greater than its surrounding pressure in the surrounding liquid, the small droplets still have not changed to gas because of Laplace pressure, which contributes to the local pressure imposed on the interior fluid of droplets due to the surface tension [44] [45] [46] .
The Laplace pressure is given by
where γ the surface tension, R is droplet radius, Pinside is the pressure inside a droplet, Poutside is the pressure outside a droplet.
Because the surface tension on the interface between water and PFP is estimated to be 56 ± 1 mN/m at 37 °C [47] , the Laplace pressure can be calculated to be 224 kPa when PFP droplets with a diameter of 1 micron is in water with 1 atmosphere pressure and the same temperature. As a result, the internal pressure of droplets is 325 kPa, produced by the value of Laplace pressure plus the surrounding water pressure of 101 kPa. Thereby, although the PFP vapor pressure is 132 kPa at 37 °C, the PFP droplets will never convert into gas because the local internal pressure of droplets remains higher than its vapor pressure. Good examples of increased boiling temperatures of PFC are given by Sheeran et al. [48, 49] .
Acoustic Droplet Vaporization
As a matter of fact, there are no considerable pressure gradients acrossing through the PFC nanoparticle droplets because the wavelengths of ultrasound (propagated in water in 37 °C) at 5 MHz, 1 MHz are 305 μm, 1.5 mm, respectively, all of which are much larger than the size of droplets. Therefore, even though the internal pressure of droplets is at a higher value due to the Laplace pressure, it will homogeneously rise and fall with the fluctuant pressure of the surrounding fluid, as Fig. 1 shows.
According to the Fig. 1 , there are circulated values of internal pressure in the PFC nanoparticle droplets, which increases above the value of vapor pressure of the PFC and then decrease below the value of vapor pressure during a pattern of acoustic pressure cycle. Herein, a time window has been shown when the internal pressure is lower than the vapor pressure. As a result, the gas phase can rapidly formed by the "driving force" if the time window is long enough (low ultrasonic frequency) or the internal pressure is small enough (high acoustic amplitude). These process has been observed by several reports [50] [51] [52] .
The phase shift capability of PFC nanoparticles will increase with increasing droplet size, ultrasound amplitude, vapor pressure and temperature. The phase shift capability of PFC nanoparticles will decrease with increasing ultrasound frequency and surface tension. Many of these results have been confirmed with experimental observations [34, 45, 53] .
Bubble Growth
The gas bubble nucleated will be continuous to grow without the limitation in terms of the heat after the increasing internal pressure of droplets ultimately exceeds the vapor pressure in the ultrasonic field, because the heat is adequate to converted into the energy demanded for satisfying the formation of the gas phase [46] . This circulation of the dynamic system has been reported by Sheeran et al. [45] and observed with PFP and PFH nanoparticle droplets in water at 25 °C and 37 °C [46] .
The eventual state of the droplets may be a dynamic equilibrium constituted by the expanded gases and condensed liquid droplets after cessation of ultrasound irradiation because the gas phases may persist in some cases. For instance, when the size of PFP droplet encapsulated a phosphatidylcholine layer, which is predicted to be a surface tension of 3.5 mN/m [54] , increases from initial 100 nm to around 517 nm by ADV, the Laplace pressure is calculated to reduce from 140 kPa to 27 kPa according to the equation (1) . At 37 °C, the PFP vapor pressure is about 132 kPa [55] , which is similar to the sum of the Laplace pressure after (27 kPa) and the atmospheric pressure (101 kPa). Thus, the gas bubble formed by ADV would be steady [22] .
Another omnipresent and more likely hypothesis is that, the noncondensable gas (e.g., nitrogen, oxygen, etc.) dissolved in the surrounding liquid may diffuse to enter into the expanding PFC gas bubbles following ADV. Maybe the PFC gas contracts back to liquid during the high pressure phase of the acoustic cycle. But the noncondensable gas does not contract as a result leaving an extremely small gas bubble that will contribute to form a larger bubble on the next acoustic cycle. This process has been observed [56] and helps to manifest that the size of gas bubbles after cessation of ultrasound irradiation is much bigger than the size expected in the initial PFC droplets [57, 58] .
The Machanism of PFC Nanoparticles for Ultrasound Theranostics Thermal Effects
Generally, the heating produced in local tissues has been depended on all sorts of external stimuli, such as high intensity focused ultrasound (HIFU) [59, 60] , radiofrequency (RF) [61, 62] , microwave (MW) [62, 63] , and laser [64] , etc., which are devoted to thermal ablation of tumor tissues [65] . In addition, even a slight temperature, for instance, produced by ultrasound, may have effective biological consequences that dramatically enhance fluidization of cell membrane [66] and permeability of blood capillaries [67] through mechanical permeabilization of cell membranes.
The drugs loaded on temperature sensitive liposomes were rapidly released in the target region by thermal effects of ultrasound at physiologically temperatures as a result of heating to generate a transition of the phospholipid membrane from a gel to a fluid [68] [69] [70] [71] . In addition, the PFC nanoparticles encapsulated doxorubicin in combination with RF ablation have been receiving clinical trials [69, 72] .
Mechanical Action of Cavitation
The cavitation of ultrasound can be significantly enhanced by the introduction of microbubbles converted by PFC nanoparticles. As a result, microbubbles have not only been used as contrast agents for ultrasound molecular imaging [73, 74] , but also as carriers to enhance genes and drugs delivery [75] [76] [77] [78] .
On the one hand, the inertial cavitation of microbubbles grown and collapsed by mechanical force in the ultrasound field can produce shock waves and microjets that can create pores in cell membranes and blood vessels thereby accelerating the permeability of genes, drugs, and their carriers [71, 79, 80] . This phenomenon that inertial cavitation results in creation of cavities in cell membranes is called sonoporation [81, 82] . On the other hand, the process that microbubbles maintain smooth oscillation when the ultrasound energy is not enough to generate inertial cavitation is called stable cavitation, which can create commutative distention and invagination of blood vessel walls. As a result, the extraordinary permeability of blood vessel and damage of the endothelial lining have been enhanced [81, 83, 84] (Fig. 2) .
Kheirolomoom et al. have reported that the development of ultrasound-reduced stable liposomes could prolong circulation time and accelerate tumor targeting [20, 86, 87] . Ultrasound-responsive cavitation has also been used to enhance permeabilization of cell membranes [88, 89] . Moreover, it has been demonstrated a probability to exceed the barrier produced by nuclear membrane in order to influence Fig. 2 The interactions between microbubbles and ultrasound. Extravasation of circulating drugs may produce by inertial cavitation events, causing to create pores in blood vessels and cell membranes. In the stable cavitation events, the smooth oscillation of microbubbles can create commutative distention and invagination of blood vessels, which also contribute to endothelial disruption and drug extravasation. The plot was adopted with permission from [85] .
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the intracellular drug distribution [90] . Drugloaded microbubbles would be attractive ultrasoundresponsive drug carriers. The approach that drugloaded microbubbles or phase-shift nanoparticles be beneficial for drug targeting to intravascular targets would be a dramatic ultrasound-responsive drug transportation [88, 89, [91] [92] [93] .
Mechanical Action of Non-cavitation
The most regular arguments of non-thermal and non-cavitation mechanisms are correlated with ultrasound radiation force and acoustic streaming. The propagation of sound across a medium induces a force in the medium that can result in suspension of particles, called the radiation force, and also translation of fluid, called acoustic streaming [94, 95] . Both radiation force and acoustic streaming advance a method to concentrate microbubbles and nanoparticles near vessel walls, which may contribute to the delivery of targeted genes and drugs.
The application of radiation force can successfully bring the delivery agents into proximity of the cells and its fragments into cell membranes [96] . A similar research utilized for improving the cellular interaction of PFC nanoparticles elucidates that ultrasound incorporated both non-targeted and targeted PFOB nanoparticles showed security on the cell survival and no changes in cell monolayers [97] . Acoustic streaming and radiation force can also enhance extravasation of PFC nanoparticles, which are loaded genes and drugs, through blood capillary for molecular ultrasound imaging and therapy [94, 95, [98] [99] [100] . Additionally, another interesting application of ultrasound radiation force was found that it was used to regulate ligand exposure on the surface of targeted microbubbles [101] . The ligands hidden by droplet shells in the initial contrast agents had been transformed to the surface of droplet shells and exposed to the cell receptor under the action of ultrasound.
Eventually, the thermal and mechanical action of ultrasound on biological tissues increase concentration of contrast agents in targeted regions, enhance extravasation of drugs, genes and their carriers, and improve diffusion of microbubbles and nanoparticles passing varieties of biological barriers throughout tumor tissues. Thereby, the traditional therapeutic efficacy are dramatically increased as a result of the enhancement of intracellular uptake on nanoparticles, genes, and drugs [19, 29, [102] [103] [104] [105] . 
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The Mechanism of PFC Nanoparticles for Drug Delivery
The characters of tumor tissue are irregular blood flow, poorly organized vascular architecture, poor vascularization, and reduced lymphatic drainage. The lack of a lymphatic system and leaky blood vessels increase the interstitial fluid pressure hampering delivery of drug carriers through blood vessel walls. However, the appropriate sized nanoparticles might accumulate in tumor tissue due to deficient tumor microvasculature system by the enhanced permeability retention (EPR) effect (illustrated in Fig. 3 ) [106] . Because of the characteristic pore cutoff size of interendothelial gaps of microvasculature system ranging from 380 to 780 nm, it is feasible for drug-loaded nanoparticles to transport themselves across large inter-endothelial gaps in a vast variety of tumors [18, 106, 107] . On the contrary, the fact that blood vessels in normal tissues have tight inter-endothelial junctions whose characteristic cutoff size is just around 7.5 nm results in a prohibition of extravasation of drug-loaded nanoparticles.
Nevertheless, the spatial heterogeneity illustrated in the distribution of inter-endothelial gaps of tumor tissues leads to a regional distribution of delivered nanoparticles [23] . This may have negative connotation for the product of tumor nanotherapy. The capability of tumor targeting may be mainly accelerated by ligand/receptor mutual effect. For example, the PFC nanoparticles targets neovasculature and/or tumors through conjugating ligands to α ν β 3 receptor, which is over expressed on the tumors, neoendothelial vasculature, and inflamed tissues [108] [109] [110] .
Drug encapsulation in nanoparticles not only radically boosts the available aqueous solubility of extremely valid drugs whose application has been considerably bound with low solubility, but also could allow drug transport to expected targets thereby remarkably weakening side effects and hinder from drug degradation under the circulation of body fluids. Even the badly toxic and unstable pharmacon, such as the peptide melittin, was successful targeted to murine tumors due to be attached to PFC nanoparticles [111, 112] . As a result, the dramatically regressive tumors without noticeable systemic toxicity were observed.
The Potential Application of PFC Nanoparticles in Medicine
The panoply of molecular imaging applications for ultrasound can be elucidated with the extensive use of contrast agents. PFC nanoparticles exhibit a good safety profile with fever or flu-like symptoms in 24 hours after dosing [24, 26] . There are no renal toxicity reported in human and animals [25] . With a nominal diameter of 250 nm around, PFC nanoparticles are not removed by the glomerular filtration but rather from the circulation by the reticuloendothelial system and then the PFC component ultimately is vaporized through respiration [27] . The blood clearance halflife of PFC nanoparticles between 3 and 42 hours due to the exact preparation method provides sufficient time for ultrasound imaging [113] . Here we review some indications for targeted and non-targeted PFC nanoparticles that are directly correlated with clinical medicine.
Vascular Imaging
Due to the enhancement of microbubbles on the back-scattered signal in ultrasound imaging, the first clinical application of phase-transition PFC nanoparticles emulsions as an ultrasound contrast agent seems to be in 1995 with a product called EchoGen [114] , which was reported to be a suspension of albumin-encapsulated PFP nanoparticles with a diameter of 0.3 μm. And the sizes of transformational bubbles tended to be between 1 and 10 μm, with an average diameter of 6 to 8 μm [16] . It could permit to enhance the contrast between the cortex and medulla of the kidney for the canine renal cortex imaging with an intravenous dose of 0.25 to 0.45 mL/kg [114] . From then onward, extensively clinic applications of EchoGen had been validly investigated on ultrasound imaging with color Doppler analysis in human kidneys [115] , left ventricular and myocardial opacification [16, [116] [117] [118] [119] , and prostates [120] . No side effects were observed and the safety evaluation of EchoGen (0.01 to 0.1 mL/kg) had been reported [121] . Besides that, another infusive imaging of EchoGen in basal cerebral arteries was covered in 1999 because that the nano-sized PFC emulsions retain a desirable high concentration for imaging where none agents had been done at that time [122] .
Unfortunately, because of the competition of Definity, a microbubble contrast agent introduced in 1999 [123] , EchoGen was not approved by the FDA in America, and apparent interest and funding vanished. However, the emulsions of PFC nanoparticle droplets still have been applied to other applications such as therapeutic delivery, vascular occlusion, and thrombosis.
Cancer Imaging
T h e c o n c e p t i o n o f p h a s e -t r a n s i t i o n P F C nanoparticles as drug carriers was initiated by Rapoport et al. In the system [124] , the increase of temperature could lead PFC nanoparticles to vaporize into microbubbles that would generate larger microbubbles by coalescence of the vaporized droplets in the hypothermia of tumor region for ultrasound imaging and therapy. The phase-transition PFC nanoparticles as effective drug carriers were first reported in this study on account of the regression of tumor growth using PFP droplets to successfully deliver doxorubicin (DOX) into tumor tissues. And then, more valuable work has been explored by Rapoport [12, 19, 29, 103] et al. For instance, the PFC nanoemulsions encapsulated paclitaxel (PTX) can enhance the ultrasoundmediated tumor imaging on the ultrasonic therapy of pancreatic cancer and breast cancer in animal models due to the significant therapeutic characterizations based on tumor regression and suppression of metastasis [29] .
Furthermore, the PFC nanoparticles can also be used for multiple modality imaging and enhancement of therapeutic efficiency of high intensity focused ultrasound (HIFU). In the most recent work, the application of enhancing ultrasound/magnetic resonance dual-modality imaging and accelerating the therapeutic efficiency of high intensity focused ultrasound (HIFU) has been observed in rabbit tumors after intravenous injection of gadolinium coated PFC nanoparticles [125] . Similar researches for multiple modality imaging and synergistic HIFU ablation of tumors are being investigated with PFC nanoparticles, such as the development of India ink incorporated phase-transition nanodroplets for photoacoustic/ ultrasound imaging and photoacoustic effect of tumor therapy [126] , and a formulation of silica coated PFC nanoemulsion encapsulating camptothecin (CPT) for synergistic effect of chemotherapy and HIFU ablation in rabbit tumors [127] .
Thrombosis Imaging
Because fibrin clots are scarce echogenic and thereby difficult to detect with ultrasound of clinical frequencies. Clinical ultrasound imaging of binding with PFC nanoparticles targeted to selected fibrin epitopes has been reported to detect the fibrin clots in vivo [17, 128, 129] . This could be useful for thrombotic diseases, such as acute kidney injury, sepsis, atherosclerosis, etc. Additionally, the detection of other constituents of thromboembolic disease has been demonstrated in ultrasound molecular imaging with targeted PFC nanoparticles. For example, Tissue Factor (TF), which is the proximate cause of thrombosis in plaque rupture and is also associated with microangiopathic thrombosis, is effectively detectable in injured vessel segments through the selective ultrasound contrast agents of PFC nanoparticles, which are targeted to TF using a specific conjugated monoclonal antibody fragment [130] [131] [132] [133] .
Vascular Occlusion
Embolotherapy is a method that is to occlude the vessel lacuna of the tissue with embolic materials such as microbubbles for treating tumors or other diseases of vascular malformations. Currently, PFC nanoparticles show promise for effectively targeted tissue occlusion [38, 134] . In Zhang et al's study, substantial localized tissue occlusion was achieved in canine kidneys by gas bubbles in the renal arteries or segmental arteries, which were generated by phase-transition PFC droplets encapsulated in lipid shells or albumin in the blood [38] . Another study by the same group results that 125 μm arterioles (average diameter) and the 4-7 μm capillary beds in Sprague-Dawley rats can be occluded with ultrasonically activated gas bubbles converted by albumin-encapsulated PFC nanoparticles (Samuel et al.) [135] .
Future perspective
An unprecedented perspective in enhancement of clinic medicine is associated with developing ultrasound-responsive phase-transition PFC contrast agents on account of the inertial characters of low solubility and diffusivity. This novel technology delineates a potential value for the applications in ultrasound molecular imaging and therapy. The special property of PFC nanoparticles illustrates an excellent opportunity to diagnose, deliver therapy and predict therapeutic efficacy with response to ultrasound.
However, the PFC nanoparticles as contrast agents still have not been widely implemented at present. Much studies in vivo need to be proceeded for fetching phase-transition PFC nanoparticles in clinical medicine. Passive targeting action of PFC nanoparticles may be more challenging in larger animals and human on account of much smaller tumor-to-body volume ratio in large animals than in small animals. Selecting more appropriate receptors is also a critical mission for active targeting action. All of these issues remain to be performed in future researches.
In the above review, we have discussed a couple of mechanisms correlating with phase-transition PFC nanoparticles for ultrasound molecular imaging and therapy and their potential applications in ultrasound medicine. Although many of these still remain in the early stage of exploitation, they must have a remarkably potential utilization for diagnose and therapy in clinical applications.
